Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

CORGENIX MEDICAL CORP (CONX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/11/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
03/11/2015 4 Tutag Robert Stanley (Director) has filed a Form 4 on CORGENIX MEDICAL CORP/CO
03/11/2015 4 SIMPSON DOUGLAS T (President/CEO) has filed a Form 4 on CORGENIX MEDICAL CORP/CO
03/11/2015 4 STEINBARGER ANN (Senior Vice President) has filed a Form 4 on CORGENIX MEDICAL CORP/CO
03/11/2015 4 Gouze Stephen P (Director) has filed a Form 4 on CORGENIX MEDICAL CORP/CO
03/11/2015 4 Walczewski Dennis (Director) has filed a Form 4 on CORGENIX MEDICAL CORP/CO
03/11/2015 4 LUDVIGSON DAVID (Director) has filed a Form 4 on CORGENIX MEDICAL CORP/CO
03/11/2015 4 Fusco Dennis (Director) has filed a Form 4 on CORGENIX MEDICAL CORP/CO
03/11/2015 4 CRITCHFIELD WILLIAM (Sr. Vice President, CFO) has filed a Form 4 on CORGENIX MEDICAL CORP/CO
03/10/2015 8-K Form 8-K - Current report
02/13/2015 10-Q Quarterly Report for the period ended December 31, 2014
12/30/2014 8-K Other Events
12/18/2014 8-K Submission of Matters to a Vote of Security Holders
12/11/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/20/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/19/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/19/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "CORGENIX SIGNS MEMORANDUM OF UNDERSTANDING REGARDING SETTLEMENT OF LITIGATION AND ANNOUNCES PLAN TO ADJOURN SPECIAL MEETING TO DECEMBER 10 DENVER — November 19, 2014 — Corgenix Medical Corporation announced today that it has entered into a memorandum of understanding with plaintiffs' counsel in the consolidated Nevada putative shareholder class action lawsuit described in the Company's definitive proxy statement dated October 21, 2014, as supplemented , in connection with the Company's proposed merger with an affiliate of Orgentec Diagnostika . The memorandum of understanding contemplates that the parties will enter into a stipulation of settlement with respect to the action. The stipulation of settlement will be subject to customary conditions, including court approval. Pursuant to the m..."
11/07/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/07/2014 10-Q Quarterly Report for the period ended September 30, 2014
10/29/2014 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Corgenix Announces Preliminary Revenue and Net Loss Results for Quarter ended September 30, 2014"
10/21/2014 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
09/17/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Form of letter to customers of Corgenix Medical Corporation"
09/17/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/10/2014 10-K Annual Report for the period ended June 30, 2014
08/28/2014 8-K Other Events, Financial Statements and Exhibits
Docs: "Minutes of Town Hall Meeting of Corgenix Medical Corporation held on August 28, 2014"
08/28/2014 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger by and among Corgenix Medical Corporation,",
"Corgenix Enters into Agreement to be Acquired by Orgentec Diagnostika",
"Voting Agreement by and among Centennial Medical Holdings, Inc. and Stephen P. Gouze, Robert Tutag, Douglass T. Simpson, William H. Critchfield and Ann L. Steinbarger"
08/28/2014 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/19/2014 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Technology Transfer, License and Product Development Agreement between the Company and Eli Lilly and Company (filed in redacted form since confidential treatment was requested pursuant to Rule 24b-2 for certain portions thereof)"
08/11/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Corgenix Provides Update on Ebola Test Kit NIH Grant"
05/15/2014 10-Q Quarterly Report for the period ended March 31, 2014
03/11/2014 8-K Other Events
02/13/2014 10-Q Quarterly Report for the period ended December 31, 2013
12/18/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Shareholder presentation material of the President and Chief Executive Officer and the Chief Financial Officer of the Company used at the Annual Meeting of Shareholders on December 17, 2013"
11/14/2013 10-Q Quarterly Report for the period ended September 30, 2013
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy